s-nitroso-n-acetylpenicillamine has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abboud, K; Bassila, JC; Ghali-Ghoul, R; Sabra, R | 1 |
| Chen, G; Hohmeier, HE; Newgard, CB; Tran, VV | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Temporal changes in vascular reactivity in early diabetes mellitus in rats: role of changes in endothelial factors and in phosphodiesterase activity.
Topics: Acetylcholine; Allopurinol; Animals; Aorta, Thoracic; Blood Glucose; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelium, Vascular; Female; Nitric Oxide Donors; Phenylephrine; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |
Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy.
Topics: Animals; Base Sequence; Cytokines; Diabetes Mellitus, Type 1; DNA Primers; Genes, bcl-2; Humans; Insulinoma; Interferon-gamma; Interleukin-1; Islets of Langerhans; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rats; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; S-Nitroso-N-Acetylpenicillamine; Tissue Engineering; Transfection; Tumor Cells, Cultured | 2003 |